Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema
ICD-10 E09.341 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema.
E09.341 refers to diabetes mellitus that is induced by drugs or chemicals, characterized by severe nonproliferative diabetic retinopathy (NPDR) with macular edema. This condition arises when certain medications, such as glucocorticoids or antipsychotics, lead to insulin resistance or impaired insulin secretion, resulting in elevated blood glucose levels. The severe NPDR indicates significant retinal damage, where the retina shows microaneurysms, retinal hemorrhages, and exudates, leading to macular edema, which can cause vision impairment. Management of this condition requires careful monitoring of blood glucose levels, typically reflected in HbA1c levels, which should ideally be maintained below 7% to prevent further complications. Insulin therapy may be necessary to achieve glycemic control, especially in cases where oral hypoglycemics are ineffective. Regular ophthalmologic evaluations are crucial to monitor the progression of retinopathy and to initiate timely interventions to preserve vision.
Comprehensive medication history, HbA1c levels, and management plans.
Patients presenting with elevated blood glucose levels and a history of medication use.
Ensure clear documentation of the relationship between medication and diabetes onset.
Detailed retinal examination findings, including descriptions of NPDR and macular edema.
Patients with diabetes presenting for routine eye exams or vision changes.
Document the severity of retinopathy and any interventions performed.
Used for follow-up visits for diabetes management.
Document the patient's diabetes management plan and any changes in medication.
Endocrinologists should ensure comprehensive documentation of diabetes control.
Medications such as glucocorticoids, thiazide diuretics, and certain antipsychotics are known to induce diabetes by affecting insulin sensitivity or secretion.
